Director Deborah Sterling, Ph.D., was quoted in the article “The Three Developments Exciting US Patent Practitioners in 2023,” published by Managing IP.

“Sterling notes that SCOTUS’s decision in Amgen v Sanofi will have to account for enablement’s role in the quid pro quo between the right to exclude and the duty for the inventor to disclose enough information to the public to promote further R&D.

‘Getting the balance right will be challenging,’ she says.”

© 2023 Managing IP is part of the Euromoney Institutional Investor PLC group.